November 26, 2009

Onno L. de Klerk, Fokko J Bosker, Antoon T. M. Willemsen, Aren van Waarde, Anniek K. D. Visser, Tim de Jager, Girstaute Dagyte, Johan A. den Boer, Rudi A Dierckx, and Peter Meerlo

Chronic stress and antidepressant treatment have opposite effects on P-glycoprotein at the blood–brain barrier: an experimental PET study in rats
J Psychopharmacol first published on November 26, 2009 as doi:10.1177/0269881109349840
[Abstract] [OnlineFirst PDF]  

Jaap G. Goekoop, Remco FP De Winter, Ron Wolterbeek, Godfried M J Van Kempen, and Victor M. Wiegant

Evidence of vasopressinergic-noradrenergic mechanisms in depression with above-normal plasma vasopressin concentration with and without psychotic features
J Psychopharmacol first published on November 26, 2009 as doi:10.1177/0269881109349839
[Abstract] [OnlineFirst PDF]  

Blanca M Bolea-Alamanac, Simon J C Davies, David M Christmas, Hazel Baxter, Sarah Cullum, and David J Nutt

Cyproterone to treat aggressivity in dementia: a clinical case and systematic review
J Psychopharmacol first published on November 26, 2009 as doi:10.1177/0269881109353460
[Abstract] [OnlineFirst PDF]  

Lucy Dunbar, Rachael Butler, Amanda Wheeler, Justin Pulford, Wayne Miles, and Janie Sheridan

Clinician experiences of employing the AmpliChip^® CYP450 test in routine psychiatric practice
J Psychopharmacol first published on November 26, 2009 as doi:10.1177/0269881109106957
[Abstract] [OnlineFirst PDF]  

David J Nutt and Stephen M Stahl

Searching for perfect sleep: the continuing evolution of GABA_A receptor modulators as hypnotics
J Psychopharmacol first published on November 26, 2009 as doi:10.1177/0269881109106927
[Abstract] [OnlineFirst PDF]  

Se Hyun Kim, Dong Chung Jung, Yong Min Ahn, and Yong Sik Kim

The combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series
J Psychopharmacol first published on November 26, 2009 as doi:10.1177/0269881109348174
[Abstract] [OnlineFirst PDF]  

Andrew B Scholey, Stephen J French, Penelope J Morris, David O Kennedy, Anthea L Milne, and Crystal F Haskell

Consumption of cocoa flavanols results in acute improvements in mood and cognitive performance during sustained mental effort
J Psychopharmacol first published on November 26, 2009 as doi:10.1177/0269881109106923
[Abstract] [OnlineFirst PDF]  

November 25, 2009

Lionel Host, Jean-Bernard Dietrich, Delphine Carouge, Dominique Aunis, and Jean Zwilller

Cocaine self-administration alters the expression of chromatin-remodelling proteins; modulation by histone deacetylase inhibition
J Psychopharmacol first published on November 25, 2009 as doi:10.1177/0269881109348173
[Abstract] [OnlineFirst PDF]  

Dinkar Sharma and Sharon Money

Carryover effects to addiction-associated stimuli in a group of marijuana and cocaine users
J Psychopharmacol first published on November 25, 2009 as doi:10.1177/0269881109350079
[Abstract] [OnlineFirst PDF]  

Noam S Katz, Bruno P Guiard, Mostafa El Mansari, and Pierre Blier

Effects of acute and sustained administration of the catecholamine reuptake inhibitor nomifensine on the firing activity of monoaminergic neurons
J Psychopharmacol first published on November 25, 2009 as doi:10.1177/0269881109348178
[Abstract] [OnlineFirst PDF]  

Kagan Gurkan, Ayhan Bilgic, Serhat Turkoglu, Birim Gunay Kilic, Ayla Aysev, and Runa Uslu

Depression, anxiety and obsessive–compulsive symptoms and quality of life in children with attention-deficit hyperactivity disorder (ADHD) during three-month methylphenidate treatment
J Psychopharmacol first published on November 25, 2009 as doi:10.1177/0269881109348172
[Abstract] [OnlineFirst PDF]  

Kenji Hashimoto

Comments on ‘The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia’
J Psychopharmacol first published on November 25, 2009 as doi:10.1177/0269881109348177
[OnlineFirst PDF]  

Laura Mattioli and Marina Perfumi

Evaluation of Rhodiola rosea L. extract on affective and physical signs of nicotine withdrawal in mice
J Psychopharmacol first published on November 25, 2009 as doi:10.1177/0269881109348166
[Abstract] [OnlineFirst PDF]  

Frank Hanisch, Julia Friedemann, and Frank Pillmann

Combined treatment with quetiapine and sertindole in therapy refractory insomnia after clozapine discontinuation
J Psychopharmacol first published on November 25, 2009 as doi:10.1177/0269881109348159
[Abstract] [OnlineFirst PDF]  

Evelin Painsipp, Herbert Herzog, and Peter Holzer

Evidence from knockout mice that neuropeptide-Y Y2 and Y4 receptor signaling prevents long-term depression-like behaviour caused by immune challenge
J Psychopharmacol first published on November 25, 2009 as doi:10.1177/0269881109348171
[Abstract] [OnlineFirst PDF]  

Karen Hewett, Michelle D. Gee, Alok Krishen, Hans-Peter Wunderlich, Alfred Le Clus, Gary Evoniuk, and Jack G. Modell

Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR
J Psychopharmacol first published on November 25, 2009 as doi:10.1177/0269881109106953
[Abstract] [OnlineFirst PDF]  

Lineke Zuurman, Paul C. C. M. Passier, Marieke L. de Kam, Huub J. Kleijn, Adam F. Cohen, and Joop M. A. van Gerven

Pharmacodynamic and pharmacokinetic effects of the intravenous CB1 receptor agonist Org 26828 in healthy male volunteers
J Psychopharmacol first published on November 25, 2009 as doi:10.1177/0269881109106913
[Abstract] [OnlineFirst PDF]  

Marije aan het Rot, Nick Coupland, Diane B. Boivin, Chawki Benkelfat, and Simon N. Young

Recognizing emotions in faces: effects of acute tryptophan depletion and bright light
J Psychopharmacol first published on November 25, 2009 as doi:10.1177/0269881109348169
[Abstract] [OnlineFirst PDF]  

Verner Knott, Adam Heenan, Dhrasti Shah, Kiley Bolton, Derek Fisher, and Crystal Villeneuve

Electrophysiological evidence of nicotine’s distracter-filtering properties in non-smokers
J Psychopharmacol first published on November 25, 2009 as doi:10.1177/0269881109348158
[Abstract] [OnlineFirst PDF]  

Anke M. W. Linssen, Wim J. Riedel, and Anke Sambeth

Effects of tyrosine/phenylalanine depletion on electrophysiological correlates of memory in healthy volunteers
J Psychopharmacol first published on November 25, 2009 as doi:10.1177/0269881109348160
[Abstract] [OnlineFirst PDF]  

Stephen R Hodgson, Rebecca S Hofford, Kris W Roberts, Dvora Eitan, Paul J Wellman, and Shoshana Eitan

Sex differences in affective response to opioid withdrawal during adolescence
J Psychopharmacol first published on November 25, 2009 as doi:10.1177/0269881109106976
[Abstract] [OnlineFirst PDF]  

Celia J. A. Morgan, Leslie Muetzelfeldt, Mark Muetzelfeldt, David J. Nutt, and H Valerie Curran

Harms associated with psychoactive substances: findings of the UK National Drug Survey
J Psychopharmacol first published on November 25, 2009 as doi:10.1177/0269881109106915
[Abstract] [OnlineFirst PDF]  

Derek G. Moore, John D. Turner, Andrew C. Parrott, Julia E. Goodwin, Sarah E. Fulton, Meeyoung O. Min, Helen C. Fox, Fleur M. B. Braddick, Emma L. Axelsson, Stephanie Lynch, Helena Ribeiro, Caroline J. Frostick, and Lynn T. Singer

During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study
J Psychopharmacol first published on November 25, 2009 as doi:10.1177/0269881109348165
[Abstract] [OnlineFirst PDF]  

Michael A Smith, Hilary L. Hii, Jonathan K. Foster, and J Anke M van Eekelen

Glucose enhancement of memory is modulated by trait anxiety in healthy adolescent males
J Psychopharmacol first published on November 25, 2009 as doi:10.1177/0269881109348164
[Abstract] [OnlineFirst PDF]  

Lucinéia dos Santos, Telma G C S de Andrade, and Frederico G Graeff

Social separation and diazepam withdrawal increase anxiety in the elevated plus-maze and serotonin turnover in the median raphe and hippocampus
J Psychopharmacol first published on November 25, 2009 as doi:10.1177/0269881109106954
[Abstract] [OnlineFirst PDF]  

Harold C. Urschel III, Larry L. Hanselka, and Michael Baron

A controlled trial of flumazenil and gabapentin for initial treatment of methylamphetamine dependence
J Psychopharmacol first published on November 25, 2009 as doi:10.1177/0269881109349837
[Abstract] [OnlineFirst PDF]  

James M Stone, Marie Raffin, Paul Morrison, and Philip K McGuire

The biological basis of antipsychotic response in schizophrenia
J Psychopharmacol first published on November 25, 2009 as doi:10.1177/0269881109106959
[Abstract] [OnlineFirst PDF]  

Samira S Valvassori, Guilherme Elias, Bruna de Souza, Fabrícia Petronilho, Felipe Dal-Pizzol, Flávio Kapczinski, Clarissa Trzesniak, Vitor Tumas, Serdar Dursun, Marcos Hortes Nisihara Chagas, Jaime E C Hallak, Antonio W Zuardi, João Quevedo, and José A. S. Crippa

Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania
J Psychopharmacol first published on November 25, 2009 as doi:10.1177/0269881109106925
[Abstract] [OnlineFirst PDF]  

November 4, 2009

Xiaolong Jiang, Zhang-jin Zhang, Steven Zhang, Eleanore H Gamble, Min Jia, Robert J Ursano, and He Li

5-HT_2A receptor antagonism by MDL 11,939 during inescapable stress prevents subsequent exaggeration of acoustic startle response and reduced body weight in rats
J Psychopharmacol first published on November 4, 2009 as doi:10.1177/0269881109106911
[Abstract] [OnlineFirst PDF]  

October 20, 2009

Helen Tibboel, Jan De Houwer, and Matt Field

Reduced attentional blink for alcohol-related stimuli in heavy social drinkers
J Psychopharmacol first published on October 20, 2009 as doi:10.1177/0269881109106977
[Abstract] [OnlineFirst PDF]  

October 14, 2009

Andrea Cipriani, Jennifer Rendell, and John R Geddes

Olanzapine in the long-term treatment of bipolar disorder: A systematic review and meta-analysis
J Psychopharmacol first published on October 14, 2009 as doi:10.1177/0269881109106900
[Abstract] [OnlineFirst PDF]  

October 13, 2009

Jean-Michel Le Melledo, Jorge Perez-Parada, Jarret Morrow, Francois Bellavance, Nathalie Lara, Farideh Jahandar, Robert Granger, Glendon Tait, and Karen McManus

Pentagastrin-induced hemoconcentration in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106922
[Abstract] [OnlineFirst PDF]  

María S García-Gutiérrez and Jorge Manzanares

The cannabinoid CB1 receptor is involved in the anxiolytic, sedative and amnesic actions of benzodiazepines
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106910
[Abstract] [OnlineFirst PDF]  

Ulrich Hegerl and R Mergl

The clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differences
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106930
[Abstract] [OnlineFirst PDF]  

Berthold Langguth, Michael Landgrebe, Markus Wittmann, Tobias Kleinjung, and Göran Hajak

Persistent tinnitus induced by tricyclic antidepressants
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106929
[OnlineFirst PDF]  

Christopher Gonano, Daniela Latzke, Manuel Sabeti-Aschraf, Stephan C Kettner, Astrid Chiari, and Burkhard Gustorff

The anxiolytic effect of pregabalin in outpatients undergoing minor orthopaedic surgery
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106928
[Abstract] [OnlineFirst PDF]  

Janice Bartholomew, Steve Holroyd, and Thomas M Heffernan

Does cannabis use affect prospective memory in young adults?
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106909
[Abstract] [OnlineFirst PDF]  

Kristina Annerbrink, Marie Olsson, Jan Hedner, and Elias Eriksson

Acute and chronic treatment with serotonin reuptake inhibitors exert opposite effects on respiration in rats: possible implications for panic disorder
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106908
[Abstract] [OnlineFirst PDF]  

Parisa Hasanein

Two histamine H₂ receptor antagonists, zolantidine and cimetidine, modulate nociception in cholestatic rats
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106912
[Abstract] [OnlineFirst PDF]  

Stefano Pallanti, Silvia Bernardi, Andrea Allen, and Eric Hollander

Serotonin function in pathological gambling: blunted growth hormone response to Sumatriptan
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106907
[Abstract] [OnlineFirst PDF]  

Wakako Umene-Nakano, Reiji Yoshimura, Nobuhisa Ueda, Akihito Suzuki, Atsuko Ikenouchi-Sugita, Hikaru Hori, Koichi Otani, and Jun Nakamura

Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106899
[Abstract] [OnlineFirst PDF]  

Natasa Hlavacova, Jan Bakos, and Daniela Jezova

Eplerenone, a selective mineralocorticoid receptor blocker, exerts anxiolytic effects accompanied by changes in stress hormone release
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106955
[Abstract] [OnlineFirst PDF]  

Joris Berwaerts, Adriaan Cleton, Stefaan Rossenu, Krishna Talluri, Bart Remmerie, Luc Janssens, Sandra Boom, Michelle Kramer, and Mariëlle Eerdekens

A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia
J Psychopharmacol first published on October 13, 2009 as doi:10.1177/0269881109106914
[Abstract] [OnlineFirst PDF]  

July 31, 2009

M Liem-Moolenaar, RWM Zoethout, P de Boer, M Schmidt, ML de Kam, AF Cohen, KL Franson, and JMA van Gerven

The effects of a glycine reuptake inhibitor R231857 on the central nervous system and on scopolamine-induced impairments in cognitive and psychomotor function in healthy subjects
J Psychopharmacol first published on July 31, 2009 as doi:10.1177/0269881109105573
[Abstract] [OnlineFirst PDF]  

SL de Haas, RC Schoemaker, JMA van Gerven, P Hoever, AF Cohen, and J Dingemanse

Pharmacokinetics, pharmacodynamics and the pharmacokinetic/pharmacodynamic relationship of zolpidem in healthy subjects
J Psychopharmacol first published on July 31, 2009 as doi:10.1177/0269881109106898
[Abstract] [OnlineFirst PDF]  

A Weinstein, J Greif, Z Yemini, H Lerman, A Weizman, and E Even-Sapir

Attenuation of cue-induced smoking urges and brain reward activity in smokers treated successfully with bupropion
J Psychopharmacol first published on July 31, 2009 as doi:10.1177/0269881109105456
[Abstract] [OnlineFirst PDF]  

July 22, 2009

JL Mace, RJ Porter, JC Dalrymple-Alford, and TJ Anderson

The effects of acute tryptophan depletion on mood in patients with Parkinson's disease and the healthy elderly
J Psychopharmacol first published on July 22, 2009 as doi:10.1177/0269881109105572
[Abstract] [OnlineFirst PDF]  

July 15, 2009

AJ Schmidt, JC Krieg, HW Clement, S Gebhardt, E Schulz, and P Heiser

Impact of drugs approved for treating ADHD on the cell survival and energy metabolism: an in-vitro study in human neuronal and immune cells
J Psychopharmacol first published on July 15, 2009 as doi:10.1177/0269881109105563
[Abstract] [OnlineFirst PDF]  

June 24, 2009

K Aitchison, K Datla, H Rooprai, J Fernando, and D Dexter

Regional distribution of clomipramine and desmethylclomipramine in rat brain and peripheral organs on chronic clomipramine administration
J Psychopharmacol first published on June 24, 2009 as doi:10.1177/0269881109105789
[Abstract] [OnlineFirst PDF]  

June 19, 2009

Nitin Gupta

Drug–drug interaction primer. A compendium of case vignettes for the practicing clinician
J Psychopharmacol first published on June 19, 2009 as doi:10.1177/0269881109102785
[OnlineFirst PDF]  

June 12, 2009

SE Osunsanmi

Clinical Manual of Child and Adolescent Psychopharmacology
J Psychopharmacol first published on June 12, 2009 as doi:10.1177/0269881108098806
[OnlineFirst PDF]  

KA Wesnes, P Annas, CJ Edgar, C Deeprose, R Karlsten, A Philipp, J Kalliomäki, and M Segerdahl

Nabilone produces marked impairments to cognitive function and changes in subjective state in healthy volunteers
J Psychopharmacol first published on June 12, 2009 as doi:10.1177/0269881109105900
[Abstract] [OnlineFirst PDF]  

June 8, 2009

EJH Mulder, L Tegaldo, P Bruschettini, and GHA Visser

Foetal response to maternal coffee intake: role of habitual versus non-habitual caffeine consumption
J Psychopharmacol first published on June 8, 2009 as doi:10.1177/0269881109106310
[Abstract] [OnlineFirst PDF]  

June 3, 2009

SE Winder-Rhodes, SR Chamberlain, MI Idris, TW Robbins, BJ Sahakian, and U Müller

Effects of modafinil and prazosin on cognitive and physiological functions in healthy volunteers
J Psychopharmacol first published on June 3, 2009 as doi:10.1177/0269881109105899
[Abstract] [OnlineFirst PDF]  

SE Gartside, NC Griffith, V Kaura, and CD Ingram

The neurosteroid dehydroepiandrosterone (DHEA) and its metabolites alter 5-HT neuronal activity via modulation of GABA_A receptors
J Psychopharmacol first published on June 3, 2009 as doi:10.1177/0269881109105836
[Abstract] [OnlineFirst PDF]  

RH Kang, HS Chang, ML Wong, MJ Choi, JY Park, HY Lee, IK Jung, SH Joe, L Kim, SH Kim, YK Kim, CS Han, BJ Ham, HJ Lee, YH Ko, MS Lee, and MS Lee

Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression
J Psychopharmacol first published on June 3, 2009 as doi:10.1177/0269881109105457
[Abstract] [OnlineFirst PDF]  

MJ Taylor, R Norbury, S Murphy, S Rudebeck, P Jezzard, and PJ Cowen

Lack of effect of citalopram on magnetic resonance spectroscopy measures of glutamate and glutamine in frontal cortex of healthy volunteers
J Psychopharmacol first published on June 3, 2009 as doi:10.1177/0269881109105679
[Abstract] [Free OnlineFirst PDF]  
SAGE Open article 

June 1, 2009

DE Tenback, PN van Harten, CJ Slooff, and J van Os

Incidence and persistence of tardive dyskinesia and extrapyramidal symptoms in schizophrenia
J Psychopharmacol first published on June 1, 2009 as doi:10.1177/0269881109106306
[Abstract] [OnlineFirst PDF]  

DJ Dijk, LM James, S Peters, JK Walsh, and S Deacon

Sex differences and the effect of gaboxadol and zolpidem on EEG power spectra in NREM and REM sleep
J Psychopharmacol first published on June 1, 2009 as doi:10.1177/0269881109105788
[Abstract] [OnlineFirst PDF]  

T C Yan, A McQuillin, A Thapar, P Asherson, S P Hunt, S C Stanford, and H Gurling

NK1 (TACR1) receptor gene 'knockout' mouse phenotype predicts genetic association with ADHD
J Psychopharmacol first published on June 1, 2009 as doi:10.1177/0269881108100255
[Abstract] [OnlineFirst PDF]  

May 28, 2009

S Vossel, J Kukolja, M Thimm, CM Thiel, and GR Fink

The effect of nicotine on visuospatial attention in chronic spatial neglect depends upon lesion location
J Psychopharmacol first published on May 28, 2009 as doi:10.1177/0269881109105397
[Abstract] [OnlineFirst PDF]  

M X Patel, P M Haddad, I B Chaudhry, S McLoughlin, N Husain, and A S David

Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years
J Psychopharmacol first published on May 28, 2009 as doi:10.1177/0269881109104882
[Abstract] [OnlineFirst PDF]  

N Yasui-Furukori, M Saito, T Nakagami, H Furukori, A Suzuki, T Kondo, and S Kaneko

Clinical response to risperidone in relation to plasma drug concentrations in acutely exacerbated schizophrenic patients
J Psychopharmacol first published on May 28, 2009 as doi:10.1177/0269881109104849
[Abstract] [OnlineFirst PDF]  

May 21, 2009

J R Cardoso de Almeida, M L Phillips, C T Cerqueira, M Zilberman, D Lobo, E Henna, H Tavares, E Amaro, C Gorenstein, V Gentil, and G F Busatto

Neural activity changes to emotional stimuli in healthy individuals under chronic use of clomipramine
J Psychopharmacol first published on May 21, 2009 as doi:10.1177/0269881109105786
[Abstract] [OnlineFirst PDF]  

S C Stanford, B J Stanford, and P K Gillman

Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium
J Psychopharmacol first published on May 21, 2009 as doi:10.1177/0269881109105450
[Abstract] [OnlineFirst PDF]  

J L Mace, R J Porter, J C Dalrymple-Alford, K A Wesnes, and T J Anderson

Effects of acute tryptophan depletion on neuropsychological and motor function in Parkinson's disease
J Psychopharmacol first published on May 21, 2009 as doi:10.1177/0269881109105721
[Abstract] [OnlineFirst PDF]  

T Schunck, A Mathis, G Erb, I J Namer, A Demazières, and R Luthringer

Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge
J Psychopharmacol first published on May 21, 2009 as doi:10.1177/0269881109104864
[Abstract] [OnlineFirst PDF]  

G Esquivel, K R Schruers, R J Maddock, A Colasanti, and E J Griez

Acids in the brain: a factor in panic?
J Psychopharmacol first published on May 21, 2009 as doi:10.1177/0269881109104847
[Abstract] [OnlineFirst PDF]  

May 7, 2009

P Celec and M Behuliak

Behavioural and endocrine effects of chronic cola intake
J Psychopharmacol first published on May 7, 2009 as doi:10.1177/0269881109105401
[Abstract] [OnlineFirst PDF]  

EL Mullings, LF Donaldson, JK Melichar, and MR Munafò

Effects of acute abstinence and nicotine administration on taste perception in cigarette smokers
J Psychopharmacol first published on May 7, 2009 as doi:10.1177/0269881109105395
[Abstract] [OnlineFirst PDF]  

C Haw and J Stubbs

Off-label psychotropic prescribing for young persons in medium security
J Psychopharmacol first published on May 7, 2009 as doi:10.1177/0269881109105102
[Abstract] [OnlineFirst PDF]  

M Vermeiden, WW van den Broek, PGH Mulder, and TK Birkenhäger

Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients
J Psychopharmacol first published on May 7, 2009 as doi:10.1177/0269881109105137
[Abstract] [OnlineFirst PDF]  

April 30, 2009

LS Volonteri, A Colasanti, G Cerveri, A Fiorentini, IF De Gaspari, MC Mauri, A Valli, P Papa, and C Mencacci

Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels
J Psychopharmacol first published on April 30, 2009 as doi:10.1177/0269881109104863
[Abstract] [OnlineFirst PDF]  

S Fokos and G Panagis

Effects of ⁹-tetrahydrocannabinol on reward and anxiety in rats exposed to chronic unpredictable stress
J Psychopharmacol first published on April 30, 2009 as doi:10.1177/0269881109104904
[Abstract] [OnlineFirst PDF]  

HW Chase, A Michael, ET Bullmore, BJ Sahakian, and TW Robbins

Paradoxical enhancement of choice reaction time performance in patients with major depression
J Psychopharmacol first published on April 30, 2009 as doi:10.1177/0269881109104883
[Abstract] [OnlineFirst PDF]  

E Boot, J Booij, JR Zinkstok, L de Haan, DH Linszen, F Baas, and TA van Amelsvoort

Striatal D₂ receptor binding in 22q11 deletion syndrome: an [¹²³I]IBZM SPECT study
J Psychopharmacol first published on April 30, 2009 as doi:10.1177/0269881109104854
[Abstract] [OnlineFirst PDF]  

April 24, 2009

J Harley, R Roberts, P Joyce, R Mulder, S Luty, C Frampton, and M Kennedy

Orosomucoid influences the response to antidepressants in major depressive disorder
J Psychopharmacol first published on April 24, 2009 as doi:10.1177/0269881109105101
[Abstract] [OnlineFirst PDF]  

R Paul, J Minay, C Cardwell, D Fogarty, and C Kelly

Meta-analysis of the effects of lithium usage on serum creatinine levels
J Psychopharmacol first published on April 24, 2009 as doi:10.1177/0269881109104930
[Abstract] [OnlineFirst PDF]  

J-Y Guo, J-Y Wang, and F Luo

Dissection of placebo analgesia in mice: the conditions for activation of opioid and non-opioid systems
J Psychopharmacol first published on April 24, 2009 as doi:10.1177/0269881109104848
[Abstract] [OnlineFirst PDF]  

J Du, A Zhang, L Wang, J Xuan, L Yu, R Che, X Li, N Gu, Z Lin, G Feng, Q Xing, and L He

Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients
J Psychopharmacol first published on April 24, 2009 as doi:10.1177/0269881109104932
[Abstract] [OnlineFirst PDF]  

V Peritogiannis and S Tsouli

Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature
J Psychopharmacol first published on April 24, 2009 as doi:10.1177/0269881109103827
[Abstract] [OnlineFirst PDF]  

April 7, 2009

PK Thanos, C Bermeo, M Rubinstein, KL Suchland, GJ Wang, DK Grandy, and ND Volkow

Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine D4 receptors
J Psychopharmacol first published on April 7, 2009 as doi:10.1177/0269881109102613
[Abstract] [OnlineFirst PDF]  

P Chandra, S Hafizi, RM Massey-Chase, GM Goodwin, PJ Cowen, and CJ Harmer

NK₁ receptor antagonism and emotional processing in healthy volunteers
J Psychopharmacol first published on April 7, 2009 as doi:10.1177/0269881109103101
[Abstract] [OnlineFirst PDF]  

A Baldacchino, IB Crome, D Zador, S McGarrol, A Taylor, S Hutchison, T Fahey, M Hickman, and B Kidd

Recording of clinical information in a Scotland-wide drug deaths study
J Psychopharmacol first published on April 7, 2009 as doi:10.1177/0269881109103797
[Abstract] [OnlineFirst PDF]  

A Pirona and MJ Morgan

An investigation of the subacute effects of ecstasy on neuropsychological performance, sleep and mood in regular ecstasy users
J Psychopharmacol first published on April 7, 2009 as doi:10.1177/0269881109102780
[Abstract] [OnlineFirst PDF]  

I Pampaloni, T Sivakumaran, CJ Hawley, A Al Allaq, J Farrow, S Nelson, and NA Fineberg

High-dose selective serotonin reuptake inhibitors in OCD: a systematic retrospective case notes survey
J Psychopharmacol first published on April 7, 2009 as doi:10.1177/0269881109104850
[Abstract] [OnlineFirst PDF]  

M Ghasemi, M Raza, and AR Dehpour

NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test
J Psychopharmacol first published on April 7, 2009 as doi:10.1177/0269881109104845
[Abstract] [OnlineFirst PDF]  

E Painsipp, G Sperk, H Herzog, and P Holzer

Delayed stress-induced differences in locomotor and depression-related behaviour in female neuropeptide-Y Y1 receptor knockout mice
J Psychopharmacol first published on April 7, 2009 as doi:10.1177/0269881109104851
[Abstract] [OnlineFirst PDF]  

April 3, 2009

T Paparrigopoulos, E Tzavellas, D Karaiskos, P Malitas, and I Liappas

An open pilot study of tiagabine in alcohol dependence: tolerability and clinical effects
J Psychopharmacol first published on April 3, 2009 as doi:10.1177/0269881109103799
[Abstract] [OnlineFirst PDF]  

CK Thoeringer, A Erhardt, I Sillaber, MB Mueller, F Ohl, F Holsboer, and ME Keck

Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice
J Psychopharmacol first published on April 3, 2009 as doi:10.1177/0269881109103091
[Abstract] [OnlineFirst PDF]  

JP Nicolay, S Gatz, F Lang, and UE Lang

Lithium-induced suicidal erythrocyte death
J Psychopharmacol first published on April 3, 2009 as doi:10.1177/0269881109102631
[Abstract] [OnlineFirst PDF]  

PC McHugh, GR Rogers, DM Glubb, PR Joyce, and MA Kennedy

Proteomic analysis of rat hippocampus exposed to the antidepressant paroxetine
J Psychopharmacol first published on April 3, 2009 as doi:10.1177/0269881109102786
[Abstract] [OnlineFirst PDF]  

S Sütt, S Raud, U Abramov, J Innos, H Luuk, M Plaas, S Kõks, K Zilmer, R Mahlapuu, M Zilmer, and E Vasar

Relation of exploratory behaviour to plasma corticosterone and Wfs1 gene expression in Wistar rats
J Psychopharmacol first published on April 3, 2009 as doi:10.1177/0269881109102738
[Abstract] [OnlineFirst PDF]  

G Martinotti, M Di Nicola, D Tedeschi, S Andreoli, D Reina, M Pomponi, M Mazza, R Romanelli, N Moroni, R De Filippis, M Di Giannantonio, G Pozzi, P Bria, and L Janiri

Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial
J Psychopharmacol first published on April 3, 2009 as doi:10.1177/0269881109102623
[Abstract] [OnlineFirst PDF]  

SJC Davies, M Esler, and DJ Nutt

Anxiety – bridging the heart/mind divide
J Psychopharmacol first published on April 3, 2009 as doi:10.1177/0269881109103800
[Abstract] [OnlineFirst PDF]  

March 27, 2009

F Klumpers, JM van Gerven, EPM Prinssen, I Niklson, F Roesch, WJ Riedel, JL Kenemans, and JMP Baas

Method development studies for repeatedly measuring anxiolytic drug effects in healthy humans
J Psychopharmacol first published on March 27, 2009 as doi:10.1177/0269881109103115
[Abstract] [OnlineFirst PDF]  

A Mead and M Li

Avoidance-suppressing effect of antipsychotic drugs is progressively potentiated after repeated administration: an interoceptive drug state mechanism
J Psychopharmacol first published on March 27, 2009 as doi:10.1177/0269881109102546
[Abstract] [OnlineFirst PDF]  

I Thompson, G Williams, B Caldwell, S Aldington, S Dickson, N Lucas, J McDowall, M Weatherall, G Robinson, and R Beasley

Randomised double-blind, placebo-controlled trial of the effects of the ‘party pills' BZP/TFMPP alone and in combination with alcohol
J Psychopharmacol first published on March 27, 2009 as doi:10.1177/0269881109102608
[Abstract] [OnlineFirst PDF]  

MJ Hunt, M Falinska, and S Kasicki

Local injection of MK801 modifies oscillatory activity in the nucleus accumbens in awake rats
J Psychopharmacol first published on March 27, 2009 as doi:10.1177/0269881109102539
[Abstract] [OnlineFirst PDF]  

RM Abou El-Magd, HK Park, T Kawazoe, S Iwana, K Ono, SP Chung, M Miyano, K Yorita, T Sakai, and K Fukui

The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of Schizophrenia
J Psychopharmacol first published on March 27, 2009 as doi:10.1177/0269881109102644
[Abstract] [OnlineFirst PDF]  

GD Cooper, AJ Goudie, and JCG Halford

Acute effects of olanzapine on behavioural expression including the behavioural satiety sequence in female rats
J Psychopharmacol first published on March 27, 2009 as doi:10.1177/0269881109102543
[Abstract] [OnlineFirst PDF]  

VSL Williams, HM Edin, SL Hogue, SE Fehnel, and DS Baldwin

Prevalence and impact of antidepressant-associated sexual dysfunction in three European countries: replication in a cross-sectional patient survey
J Psychopharmacol first published on March 27, 2009 as doi:10.1177/0269881109102779
[Abstract] [OnlineFirst PDF]  

March 20, 2009

J Daumann, D Wagner, K Heekeren, A Neukirch, CM Thiel, and E Gouzoulis-Mayfrank

Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis
J Psychopharmacol first published on March 20, 2009 as doi:10.1177/0269881109103227
[Abstract] [OnlineFirst PDF]  

JC Shan, MH Hsieh, CC Liu, CC Wen, and CM Liu

Clinical alertness to valproic acid-induced hyperammonemia—two case reports
J Psychopharmacol first published on March 20, 2009 as doi:10.1177/0269881109102635
[OnlineFirst PDF]  

FM Van der Veen, EAT Evers, GW Mies, EFPM Vuurman, and J Jolles

Acute tryptophan depletion selectively attenuates cardiac slowing in an Eriksen flanker task
J Psychopharmacol first published on March 20, 2009 as doi:10.1177/0269881109103801
[Abstract] [OnlineFirst PDF]  

E Sacchetti, C Turrina, B Cesana, and G Mazzaglia

Timing of stroke in elderly people exposed to typical and atypical antipsychotics: a replication cohort study after the paper of Kleijer, et al.
J Psychopharmacol first published on March 20, 2009 as doi:10.1177/0269881109103202
[OnlineFirst PDF]  

M Wienberg, BY Glenthoj, KS Jensen, and B Oranje

A single high dose of escitalopram increases mismatch negativity without affecting processing negativity or P300 amplitude in healthy volunteers
J Psychopharmacol first published on March 20, 2009 as doi:10.1177/0269881109102606
[Abstract] [OnlineFirst PDF]  

MX Patel, N de Zoysa, M Bernadt, J Bindman, and AS David

Are depot antipsychotics more coercive than tablets?
J Psychopharmacol first published on March 20, 2009 as doi:10.1177/0269881109103133
[Abstract] [OnlineFirst PDF]  

MG Bossong, TM Brunt, JP Van Dijk, SM Rigter, J Hoek, HMJ Goldschmidt, and RJM Niesink

mCPP: an undesired addition to the ecstasy market
J Psychopharmacol first published on March 20, 2009 as doi:10.1177/0269881109102541
[Abstract] [OnlineFirst PDF]  

JL Wilkinson, FI Carroll, and RA Bevins

An investigation of bupropion substitution for the interoceptive stimulus effects of nicotine
J Psychopharmacol first published on March 20, 2009 as doi:10.1177/0269881109102518
[Abstract] [OnlineFirst PDF]  

V Raj, HC Liang, ND Woodward, AL Bauernfeind, J Lee, MS Dietrich, S Park, and RL Cowan

MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study
J Psychopharmacol first published on March 20, 2009 as doi:10.1177/0269881109103203
[Abstract] [OnlineFirst PDF]  

RK Singh, C Jia, F Garcia, GA Carrasco, G Battaglia, and NA Muma

Activation of the JAK-STAT pathway by olanzapine is necessary for desensitization of serotonin2A receptor–stimulated phospholipase C signaling in rat frontal cortex but not serotonin2A receptor–stimulated hormone release
J Psychopharmacol first published on March 20, 2009 as doi:10.1177/0269881109103090
[Abstract] [OnlineFirst PDF]  

RIG Holt, T Abdelrahman, M Hirsch, Z Dhesi, T George, T Blincoe, and RC Peveler

The prevalence of undiagnosed metabolic abnormalities in people with serious mental illness
J Psychopharmacol first published on March 20, 2009 as doi:10.1177/0269881109102788
[Abstract] [OnlineFirst PDF]  

March 13, 2009

MR Munafò, JE Bailey, A Diaper, RM Cooper, CP Benton, IS Penton-Voak, and DJ Nutt

RETRACTION: Effects of 7.5% CO₂ inhalation on allocation of spatial attention to facial cues of emotional expression
J Psychopharmacol first published on March 13, 2009 as doi:10.1177/0269881108096981
[OnlineFirst PDF]  

March 12, 2009

R Molteni, F Calabrese, S Chourbaji, C Brandwein, G Racagni, P Gass*, and MA Riva*

Depression-prone mice with reduced glucocorticoid receptor expression display an altered stress-dependent regulation of brain-derived neurotrophic factor and activity-regulated cytoskeleton-associated protein
J Psychopharmacol first published on March 12, 2009 as doi:10.1177/0269881108099815
[Abstract] [OnlineFirst PDF]  

ML Lu, CH Chen, HC Liu, PY Chen, SH Yu, and CC Chiu

RETRACTION: The biphasic changes of insulin secretion in schizophrenic patients treated with olanzapine
J Psychopharmacol first published on March 12, 2009 as doi:10.1177/0269881108094888
[OnlineFirst PDF]  

P Heiser, O Sommer, AJ Schmidt, HW Clement, A Hoinkes, UT Hopt, E Schulz, JC Krieg, and E Dobschütz

Effects of antipsychotics and vitamin C on the formation of reactive oxygen species
J Psychopharmacol first published on March 12, 2009 as doi:10.1177/0269881109102538
[Abstract] [OnlineFirst PDF]  

J Seguí, F López-Muñoz, C Álamo, X Camarasa, P García-García, and A Pardo

Effects of adjunctive reboxetine in patients with duloxetine-resistant depression: a 12-week prospective study
J Psychopharmacol first published on March 12, 2009 as doi:10.1177/0269881109102641
[Abstract] [OnlineFirst PDF]  

T Uzbay, H Kayir, G Goktalay, and M Yildirim

Agmatine disrupts prepulse inhibition of acoustic startle reflex in rats
J Psychopharmacol first published on March 12, 2009 as doi:10.1177/0269881109102533
[Abstract] [OnlineFirst PDF]  

E Bianchi, D Lehmann, E Vivoli, M Norcini, and C Ghelardini

Involvement of PLC-₃ in the effect of morphine on memory retrieval in passive avoidance task
J Psychopharmacol first published on March 12, 2009 as doi:10.1177/0269881108102013
[Abstract] [OnlineFirst PDF]  

BC Jones, S Ben-Hamida, A Pereira de Vasconcelos, C Kelche, C Lazarus, R Jackisch, and JC Cassel

Effects of ethanol and ecstasy on conditioned place preference in the rat
J Psychopharmacol first published on March 12, 2009 as doi:10.1177/0269881109102775
[Abstract] [OnlineFirst PDF]  

J Harley, S Luty, J Carter, R Mulder, and P Joyce

Elevated C-reactive protein in depression: a predictor of good long-term outcome with antidepressants and poor outcome with psychotherapy
J Psychopharmacol first published on March 12, 2009 as doi:10.1177/0269881109102770
[OnlineFirst PDF]  

D Taylor and V Cornelius

Risperidone long-acting injection: factors associated with changes in bed stay and hospitalisation in a 3-year naturalistic follow-up
J Psychopharmacol first published on March 12, 2009 as doi:10.1177/0269881109102611
[Abstract] [OnlineFirst PDF]  

March 5, 2009

S Ratcliffe, M Younus, M Hauben, and L Reich

Antidepressants that inhibit neuronal norepinephrine reuptake are not associated with increased spontaneous reporting of cardiomyopathy
J Psychopharmacol first published on March 5, 2009 as doi:10.1177/0269881108100776
[Abstract] [OnlineFirst PDF]  

SL McLean, ML Woolley, and JC Neill

Effects of subchronic phencyclidine on behaviour of female rats on the elevated plus maze and open field
J Psychopharmacol first published on March 5, 2009 as doi:10.1177/0269881109103112
[Abstract] [OnlineFirst PDF]  

A Attard, G Ranjith, and D Taylor

Alternative routes to oral antidepressant therapy: case vignette and literature review
J Psychopharmacol first published on March 5, 2009 as doi:10.1177/0269881109102545
[OnlineFirst PDF]  

RP Markus, DG Franco, LA Carvalho, V Gentil, and C Gorenstein

Acute increase in urinary 6-sulfatoximelatonin after clomipramine, as a predictive measure for emotional improvement
J Psychopharmacol first published on March 5, 2009 as doi:10.1177/0269881109102542
[Abstract] [OnlineFirst PDF]  

R Hanwella, V de Silva, C Wijeratne, T Ketharanathan, and J de Silva

Clozapine-associated weight loss
J Psychopharmacol first published on March 5, 2009 as doi:10.1177/0269881109102530
[Abstract] [OnlineFirst PDF]  

M Kuloglu, O Ekinci, and A Caykoylu

Venlafaxine-associated nocturnal bruxism in a depressive patient successfully treated with buspirone
J Psychopharmacol first published on March 5, 2009 as doi:10.1177/0269881109102612
[OnlineFirst PDF]  

February 27, 2009

KA Brennan, RA Lea, PS Fitzmaurice, and P Truman

Nicotinic receptors and stages of nicotine dependence
J Psychopharmacol first published on February 27, 2009 as doi:10.1177/0269881108100256
[Abstract] [OnlineFirst PDF]  

C Garcia-Leal, CM Del-Ben, FM Leal, FG Graeff, and FS Guimarães

Escitalopram prolonged fear induced by simulated public speaking and released hypothalamic-pituitary-adrenal axis activation
J Psychopharmacol first published on February 27, 2009 as doi:10.1177/0269881108101782
[Abstract] [OnlineFirst PDF]  

February 24, 2009

C Bushe, J Sniadecki, AJ Bradley, and V Poole Hoffmann

Comparison of metabolic and prolactin variables from a six-month randomised trial of olanzapine and quetiapine in schizophrenia
J Psychopharmacol first published on February 24, 2009 as doi:10.1177/0269881108101783
[Abstract] [OnlineFirst PDF]  

AA-B Badawy

Plasma free tryptophan revisited: what you need to know and do before measuring it
J Psychopharmacol first published on February 24, 2009 as doi:10.1177/0269881108098965
[Abstract] [OnlineFirst PDF]  

B Boland, L Mitcheson, and K Wolff

Lhermitte's sign, Electric shock sensations and high dose ecstasy consumption: preliminary findings
J Psychopharmacol first published on February 24, 2009 as doi:10.1177/0269881108100528
[Abstract] [OnlineFirst PDF]  

February 9, 2009

SJ Mathew, RB Price, DC Shungu, X Mao, ELP Smith, JM Amiel, and JD Coplan

A pilot study of the effects of chronic paroxetine administration on hippocampal N-acetylaspartate in generalized anxiety disorder
J Psychopharmacol first published on February 9, 2009 as doi:10.1177/0269881108101796
[Abstract] [OnlineFirst PDF]  

J Cilia, JE Gartlon, C Shilliam, LA Dawson, SH Moore, and DNC Jones

Further neurochemical and behavioural investigation of Brattleboro rats as a putative model of schizophrenia
J Psychopharmacol first published on February 9, 2009 as doi:10.1177/0269881108098787
[Abstract] [OnlineFirst PDF]  

January 22, 2009

K Hewett, W Chrzanowski, R Jokinen, R Felgentreff, RK Shrivastava, MD Gee, DS Wightman, MC O'Leary, LS Millen, MC Leon, MA Briggs, A Krishen, and JG Modell

Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorder
J Psychopharmacol first published on January 22, 2009 as doi:10.1177/0269881108100254
[Abstract] [OnlineFirst PDF]  

M Rezayat, H Niasari, S Ahmadi, L Parsaei, and MR Zarrindast

N-methyl-D-aspartate receptors are involved in lithium-induced state-dependent learning in mice
J Psychopharmacol first published on January 22, 2009 as doi:10.1177/0269881108100093
[Abstract] [OnlineFirst PDF]  

JB Diniz, RG Shavitt, CAB Pereira, AG Hounie, I Pimentel, LM Koran, SM Dainesi, and EC Miguel

Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial
J Psychopharmacol first published on January 22, 2009 as doi:10.1177/0269881108099423
[Abstract] [OnlineFirst PDF]  

D Élie, M Poirier, JM Chianetta, M Durand, CA Grégoire, and S Grignon

Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder
J Psychopharmacol first published on January 22, 2009 as doi:10.1177/0269881108100777
[Abstract] [OnlineFirst PDF]  

AC Mishra and B Mohanty

Effect of lactational exposure of olanzapine on body weight of mice: a comparative study on neonates of both the sexes during post-natal development
J Psychopharmacol first published on January 22, 2009 as doi:10.1177/0269881108100775
[Abstract] [OnlineFirst PDF]  

P Shajahan and M Taylor

The uses and outcomes of quetiapine in depressive and bipolar mood disorders in clinical practice
J Psychopharmacol first published on January 22, 2009 as doi:10.1177/0269881108100774
[Abstract] [OnlineFirst PDF]  

J Nielsen, M Dahm, H Lublin, and D Taylor

Psychiatrists' attitude towards and knowledge of clozapine treatment
J Psychopharmacol first published on January 22, 2009 as doi:10.1177/0269881108100320
[Abstract] [OnlineFirst PDF]  

OJ Robinson, R Cools, MJ Crockett, and BJ Sahakian

Mood state moderates the role of serotonin in cognitive biases
J Psychopharmacol first published on January 22, 2009 as doi:10.1177/0269881108100257
[Abstract] [OnlineFirst PDF]  

GJH Dumont, RC Schoemaker, DJ Touw, FCGJ Sweep, JK Buitelaar, JMA van Gerven, and RJ Verkes

Acute psychomotor effects of MDMA and ethanol (co-) administration over time in healthy volunteers
J Psychopharmacol first published on January 22, 2009 as doi:10.1177/0269881108099214
[Abstract] [OnlineFirst PDF]  

SR Hodgson, RS Hofford, SG Buckman, PJ Wellman, and S Eitan

Morphine-induced stereotyped thigmotaxis could appear as enhanced fear and anxiety in some behavioural tests
J Psychopharmacol first published on January 22, 2009 as doi:10.1177/0269881108100797
[Abstract] [OnlineFirst PDF]  

K Boora, K Chiappone, S Dubovsky, and J Xu

Ziprasidone-induced spontaneous orgasm
J Psychopharmacol first published on January 22, 2009 as doi:10.1177/0269881108100321
[Abstract] [OnlineFirst PDF]  

December 12, 2008

JA Milstein, JW Dalley, and TW Robbins

Methylphenidate-induced impulsivity: pharmacological antagonism by -adrenoreceptor blockade
J Psychopharmacol first published on December 12, 2008 as doi:10.1177/0269881108098146
[Abstract] [OnlineFirst PDF]  

GJH Dumont, C Kramers, FCGJ Sweep, JJ Willemsen, DJ Touw, RC Schoemaker, JMA van Gerven, JK Buitelaar, and RJ Verkes

Ethanol co-administration moderates 3,4-methylenedioxymethamphetamine effects on human physiology
J Psychopharmacol first published on December 12, 2008 as doi:10.1177/0269881108100020
[Abstract] [OnlineFirst PDF]  

K Sugden, CM Pariante, P McGuffin, KJ Aitchison, and UM D'Souza

Housekeeping gene expression is affected by antidepressant treatment in a mouse fibroblast cell line
J Psychopharmacol first published on December 12, 2008 as doi:10.1177/0269881108099690
[Abstract] [OnlineFirst PDF]  

M Kuloglu, A Caykoylu, O Ekinci, D Bayindirli, G Vural, and O Deniz

Successful management of depression with reboxetine in a patient who developed parkinsonism related to paroxetine use
J Psychopharmacol first published on December 12, 2008 as doi:10.1177/0269881108099962
[OnlineFirst PDF]  

LAW Jans, GAH Korte-Bouws, SM Korte, and A Blokland

The effects of acute tryptophan depletion on affective behaviour and cognition in Brown Norway and Sprague Dawley rats
J Psychopharmacol first published on December 12, 2008 as doi:10.1177/0269881108099424
[Abstract] [OnlineFirst PDF]  

E Vieta, T Ramey, D Keller, PA English, AD Loebel, and J Miceli

Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study
J Psychopharmacol first published on December 12, 2008 as doi:10.1177/0269881108099418
[Abstract] [OnlineFirst PDF]  

M Poyurovsky, I Glick, and LM Koran

Lamotrigine augmentation in schizophrenia and schizoaffective patients with obsessive-compulsive symptoms
J Psychopharmacol first published on December 12, 2008 as doi:10.1177/0269881108099215
[Abstract] [OnlineFirst PDF]  

MA van Duinen, KRJ Schruers, and EJL Griez

Desynchrony of fear in phobic exposure
J Psychopharmacol first published on December 12, 2008 as doi:10.1177/0269881108098821
[Abstract] [OnlineFirst PDF]  

CA Hendrie

The funding crisis in psychopharmacology: an historical perspective
J Psychopharmacol first published on December 12, 2008 as doi:10.1177/0269881108100253
[OnlineFirst PDF]  

November 27, 2008

HY Chan, CJ Chang, SC Chiang, JJ Chen, CH Chen, HJ Sun, HG Hwu, and MS Lai

A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism
J Psychopharmacol first published on November 27, 2008 as doi:10.1177/0269881108096070
[Abstract] [OnlineFirst PDF]  

November 21, 2008

JL Kenemans, W Hebly, EHM van den Heuvel, and T Grent-'T-Jong

Moderate alcohol disrupts a mechanism for detection of rare events in human visual cortex
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108098868
[Abstract] [OnlineFirst PDF]  

A Caykoylu, O Ekinci, M Kuloglu, and O Deniz

Aripiprazole-induced rabbit syndrome: a case report
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108098145
[Abstract] [OnlineFirst PDF]  

LN Ravindran, SM Jung, and AV Ravindran

Intravenous anti-obsessive agents: a review
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108096508
[Abstract] [OnlineFirst PDF]  

AL Montejo, N Prieto, A Terleira, J Matias, S Alonso, G Paniagua, S Naval, DG Parra, C Gabriel, E Mocaër, and A Portolés

Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108096507
[Abstract] [OnlineFirst PDF]  

JCG Halford, EJ Boyland, SJ Cooper*, TM Dovey, MSB Huda, CT Dourish, GR Dawson, and JPH Wilding

The effects of sibutramine on the microstructure of eating behaviour and energy expenditure in obese women
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108095195
[Abstract] [OnlineFirst PDF]  

AW Zuardi, JAS Crippa, SM Dursun, SL Morais, JAA Vilela, RF Sanches, and JEC Hallak

Cannabidiol was ineffective for manic episode of bipolar affective disorder
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108096521
[Abstract] [OnlineFirst PDF]  

SL McLean, B Grayson, M Harris, C Protheroe, S Bate, ML Woolley, and JC Neill

Isolation rearing impairs novel object recognition and attentional set shifting performance in female rats
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108093842
[Abstract] [OnlineFirst PDF]  

S Bae, JE Kim, J Hwang, YS Lee, HH Lee, J Lee, IK Lyoo, PF Renshaw, and SJ Yoon

Increased prevalence of white matter hyperintensities in patients with panic disorder
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108098476
[Abstract] [OnlineFirst PDF]  

L Zuurman, C Roy, RC Schoemaker, A Amatsaleh, L Guimaeres, JL Pinquier, AF Cohen, and JMA van Gerven

Inhibition of THC-induced effects on the central nervous system and heart rate by a novel CB1 receptor antagonist AVE1625
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108096509
[Abstract] [OnlineFirst PDF]  

KJ Wagner, M Valet, EF Kochs, M Kriner, TR Tölle, and T Sprenger

The µ-opioid receptor agonist remifentanil induces acute dysphoria irrespective of its analgesic properties
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108095811
[Abstract] [OnlineFirst PDF]  

N Cheesman and D Taylor

Psychosis and depression associated with alteration to amiodarone therapy
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108095717
[Abstract] [OnlineFirst PDF]  

L Craig, JE Fisk, C Montgomery, PN Murphy, and M Wareing

Is emotional intelligence impaired in ecstasy-polydrug users?
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108095713
[Abstract] [OnlineFirst PDF]  

FI Tarazi, T Moran-Gates, EHF Wong, B Henry, and M Shahid

Asenapine induces differential regional effects on serotonin receptor subtypes
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108095704
[Abstract] [OnlineFirst PDF]  

RZ Goldstein, PA Woicik, SJ Moeller, F Telang, M Jayne, C Wong, GJ Wang, JS Fowler, and ND Volkow

Liking and wanting of drug and non-drug rewards in active cocaine users: the STRAP-R questionnaire
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108096982
[Abstract] [OnlineFirst PDF]  

AJ Schmidt, JC Krieg, HW Clement, UM Hemmeter, E Schulz, H Vedder, and P Heiser

Effects of quetiapine, risperidone, 9-hydroxyrisperidone and ziprasidone on the survival of human neuronal and immune cells in vitro
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108096506
[Abstract] [OnlineFirst PDF]  

A.F. Buchmann, M. Laucht, B. Schmid, K. Wiedemann, K. Mann, and U.S. Zimmermann

Cigarette craving increases after a psychosocial stress test and is related to cortisol stress response but not to dependence scores in daily smokers
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108095716
[Abstract] [OnlineFirst PDF]  

N Ahuja, N Palanichamy, P Mackin, and AJ Lloyd

Olanzapine-induced hyperglycaemic coma and neuroleptic malignant syndrome: case report and review of literature
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108096901
[Abstract] [OnlineFirst PDF]  

R Ghanbari, M El Mansari, and P Blier

Electrophysiological effects of the co-administration of escitalopram and bupropion on rat serotonin and norepinephrine neurons
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108095714
[Abstract] [OnlineFirst PDF]  

S Bellino, E Paradiso, P Bozzatello, and F Bogetto

Efficacy and tolerability of duloxetine in the treatment of patients with borderline personality disorder: a pilot study
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108095715
[Abstract] [OnlineFirst PDF]  

GE Jacobs, IMC Kamerling, ML de Kam, RH DeRijk, J van Pelt, FG Zitman, and JMA van Gerven

Enhanced tolerability of the 5-hydroxytryptophane challenge test combined with granisetron
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108094299
[Abstract] [OnlineFirst PDF]  

WTCJ Heijnen, WW van den Broek, PGH Mulder, and TK Birkenhäger

Prevalence of trait anxiety in a sample of depressed inpatients and its influence on response to antidepressants
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108099213
[Abstract] [OnlineFirst PDF]  

D Van Dam, K Coen, and PP De Deyn

Ibuprofen modifies cognitive disease progression in an Alzheimer's mouse model
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108097630
[Abstract] [OnlineFirst PDF]  

KP Hayhurst, RJ Drake, and SW Lewis

Patient factors associated with receipt of combination antipsychotic drug therapy in the treatment of schizophrenia
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108095169
[Abstract] [OnlineFirst PDF]  

M Liem-Moolenaar, FA Gray, SJ de Visser, KL Franson, RC Schoemaker, JAJ Schmitt, AF Cohen, and JMA van Gerven

Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108094524
[Abstract] [OnlineFirst PDF]  

S Pallanti, S Bernardi, A Allen, W Chaplin, D Watner, CM DeCaria, and E Hollander

Noradrenergic function in pathological gambling: blunted growth hormone response to clonidine
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108099419
[Abstract] [OnlineFirst PDF]  

D Dickerson, B Pittman, E Ralevski, A Perrino, D Limoncelli, J Edgecombe, G Acampora, JH Krystal, and I Petrakis

Ethanol-like effects of thiopental and ketamine in healthy humans
J Psychopharmacol first published on November 21, 2008 as doi:10.1177/0269881108098612
[Abstract] [OnlineFirst PDF]  

November 14, 2008

G Laretzaki, S Plainis, S Argyropoulos, IG Pallikaris, and P Bitsios

Threat and anxiety affect visual contrast perception
J Psychopharmacol first published on November 14, 2008 as doi:10.1177/0269881108098823
[Abstract] [OnlineFirst PDF]  

S Bernardi and S Pallanti

Successful duloxetine treatment of a binge eating disorder: a case report
J Psychopharmacol first published on November 14, 2008 as doi:10.1177/0269881108098822
[Abstract] [OnlineFirst PDF]  

Ö Uzun

Lamotrigine as an augmentation agent in treatment-resistant obsessive-compulsive disorder: a case report
J Psychopharmacol first published on November 14, 2008 as doi:10.1177/0269881108098809
[Abstract] [OnlineFirst PDF]  

October 28, 2008

AKK Chung and SE Chua

Torsade de pointes associated with low-dose amisulpride: a case report
J Psychopharmacol first published on October 28, 2008 as doi:10.1177/0269881108098385
[OnlineFirst PDF]  

October 6, 2008

AA Gibbs, KH Naudts, EP Spencer, and AS David

Effects of amisulpride on emotional memory using a dual-process model in healthy male volunteers
J Psychopharmacol first published on October 6, 2008 as doi:10.1177/0269881108097722
[Abstract] [OnlineFirst PDF]  

C Norman, SK Grimond-Billa, GW Bennett, and HJ Cassaday

A neurotensin agonist and antagonist decrease and increase activity, respectively, but do not preclude discrete cue conditioning
J Psychopharmacol first published on October 6, 2008 as doi:10.1177/0269881108097721
[Abstract] [OnlineFirst PDF]  

S Flaisher-Grinberg, N Kronfeld-Schor, and H Einat

Models of mania: from facets to domains and from animal models to model animals
J Psychopharmacol first published on October 6, 2008 as doi:10.1177/0269881108097905
[OnlineFirst PDF]  

K Domschke, J Deckert, V Arolt, and BT Baune

Anxious versus non-anxious depression: difference in treatment outcome
J Psychopharmacol first published on October 6, 2008 as doi:10.1177/0269881108097723
[OnlineFirst PDF]  

EA Del-Bel, FS Guimarães, SRL Joca, MB Echeverry, and FR Ferreira

Tolerance to the cataleptic effect that follows repeated nitric oxide synthase inhibition may be related to functional enzymatic recovery
J Psychopharmacol first published on October 6, 2008 as doi:10.1177/0269881108097717
[Abstract] [OnlineFirst PDF]  

V De Luca, S Tharmalingam, C Zai, N Potapova, J Strauss, J Vincent, and JL Kennedy

Association of HPA axis genes with suicidal behaviour in schizophrenia
J Psychopharmacol first published on October 6, 2008 as doi:10.1177/0269881108097817
[Abstract] [OnlineFirst PDF]  

Luísa W. Bisol and Diogo R. Lara

Low-dose quetiapine for patients with dysregulation of hyperthymic and cyclothymic temperaments
J Psychopharmacol first published on October 6, 2008 as doi:10.1177/0269881108097715
[Abstract] [OnlineFirst PDF]  

SD Hood, JP Potokar, SJC Davies, DA Hince, K Morris, KM Seddon, DJ Nutt, and SV Argyropoulos

Dopaminergic challenges in social anxiety disorder: evidence for dopamine D₃ desensitisation following successful treatment with serotonergic antidepressants
J Psychopharmacol first published on October 6, 2008 as doi:10.1177/0269881108098144
[Abstract] [OnlineFirst PDF]  

October 2, 2008

DW Boulton, AH Balch, K Royzman, CG Patel, RM Berman, S Mallikaarjun, and RA Reeves

The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder
J Psychopharmacol first published on October 2, 2008 as doi:10.1177/0269881108096522
[Abstract] [OnlineFirst PDF]  

R Whale, T Terao, P Cowen, N Freemantle, and J Geddes

Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: a systematic review
J Psychopharmacol first published on October 2, 2008 as doi:10.1177/0269881108097714
[Abstract] [OnlineFirst PDF]  

C Chiamulera, V Tedesco, L Zangrandi, C Giuliano, and G Fumagalli

Propranolol transiently inhibits reinstatement of nicotine-seeking behaviour in rats
J Psychopharmacol first published on October 2, 2008 as doi:10.1177/0269881108097718
[Abstract] [OnlineFirst PDF]  

G Bedi, NT Van Dam, and J Redman

Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use
J Psychopharmacol first published on October 2, 2008 as doi:10.1177/0269881108097631
[Abstract] [OnlineFirst PDF]  

JR Davidson, W Zhang, KM Connor, J Ji, K Jobson, Y Lecrubier, AC McFarlane, DJ Newport, DJ Nutt, DN Osser, DJ Stein, ZN Stowe, O Tajima, and M Versiani

A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD)
J Psychopharmacol first published on October 2, 2008 as doi:10.1177/0269881108096505
[Abstract] [OnlineFirst PDF]  

I Labuschagne, RJ Croft, KL Phan, and PJ Nathan

Augmenting serotonin neurotransmission with citalopram modulates emotional expression decoding but not structural encoding of moderate intensity sad facial emotional stimuli: an event-related potential (ERP) investigation
J Psychopharmacol first published on October 2, 2008 as doi:10.1177/0269881108097878
[Abstract] [OnlineFirst PDF]  

SJ Kish, PS Fitzmaurice, LJ Chang, Y Furukawa, and J Tong

Low striatal serotonin transporter protein in a human polydrug MDMA (ecstasy) user: a case study
J Psychopharmacol first published on October 2, 2008 as doi:10.1177/0269881108097724
[Abstract] [OnlineFirst PDF]  

A Papadopoulos, A Rich, DJ Nutt, and JE Bailey

The effects of single dose anxiolytic medication on the CO₂ models of anxiety: differentiation of subjective and objective measures
J Psychopharmacol first published on October 2, 2008 as doi:10.1177/0269881108097716
[Abstract] [OnlineFirst PDF]  

September 18, 2008

L E Hill, S K Droste, D J Nutt, A C E Linthorst, and J M H M Reul

Voluntary exercise alters GABA_A receptor subunit and glutamic acid decarboxylase-67 gene expression in the rat forebrain
J Psychopharmacol first published on September 18, 2008 as doi:10.1177/0269881108096983
[Abstract] [OnlineFirst PDF]  

A Whitworth, C Stuppaeck, K Yazdi, K Kralovec, C Geretsegger, G Zernig, and W Aichhorn

Olanzapine and breast-feeding: changes of plasma concentrations of olanzapine in a breast-fed infant over a period of 5 months
J Psychopharmacol first published on September 18, 2008 as doi:10.1177/0269881108096504
[Abstract] [OnlineFirst PDF]  

May 30, 2008

A Tint, P M Haddad, and I M Anderson

The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study
J Psychopharmacol first published on May 30, 2008 as doi:10.1177/0269881107087488
[Abstract] [OnlineFirst PDF]